Latest news articles

Added 3 days ago Drug news

Six-year Ocrevus data showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

Genentech,, announced longer-term data from the Phase III open-label extension studies of OPERA I, OPERA II and ORATORIO showed that...

Added 4 days ago Drug news

New five-year disease stability data confirm the long-term efficacy and safety of Mavenclad as a treatment for multiple sclerosis

Merck KGaA announced the presentation of new data for Mavenclad (cladribine tablets), which further characterise the long-term efficacy and safety...

Added 5 days ago Drug news

Phase III OPTIMUM study of ponesimod shows efficacy in multiple sclerosis

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the results from the Phase III OPTIMUM study for ponesimod, an...

Search all news articles for Multiple sclerosis

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

EPNS 2019 Congress Highlights

EPNS 2019 Congress Highlights

The team is creating daily reports from the 13th European Paediatric Neurology Society (EPNS) Congress, held in Athens, Greece from 17th to 21st September 2019, to bring you coverage of cutting-edge science and advances in clinical care across all fields of paediatric neurology. 

Migraine Knowledge Centre

Migraine Knowledge Centre

The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.

Load more


Multiple sclerosis in adults: management

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management...

Added 4 years ago

Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis

This 2015 revised guideline replaces former versions. It includes all newly approved or licensed treatments for MS and represents a consensus concerning their use.

Added 4 years ago

Urinary incontinence in neurological disease: assessment and management

This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease.

Added 7 years ago

Search all guidelines for Multiple sclerosis

Journal articles

The hippocampus in multiple sclerosis.

Some of the clinical manifestations of multiple sclerosis, such as memory impairment and depression, are, at least partly, related to involvement of the hippocampus. Pathological studies have shown extensive demyelination...

Added 3 months ago

Multiple sclerosis: effect of beta interferon treatment on survival.

Worldwide, the beta interferons remain the most commonly prescribed disease-modifying drugs for multiple sclerosis. However, it is unclear if they alter survival. We investigated the association between beta interferon and mortality...

Added 3 months ago

How people with multiple sclerosis experience the influence of nutrition and lifestyle factors on the disease.

Purpose: Increasing knowledge suggests that nutrition and lifestyle factors affect multiple sclerosis. This study explores how people with multiple sclerosis experience daily multiple sclerosis disease activity and the influence...

Added 3 months ago

Search all journal articles for Multiple sclerosis

Clinical trials

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple sclerosis (RRMS) and to assess the pharmacokinetics (PK) of BIIB017 in pediatric participants...

Added 3 months ago

Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

To determine the efficacy of SAR442168 in reducing the number of new brain lesions reported in Magnetic Resonance Imaging (MRI)

Added 3 months ago

Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants

The main objective of the study is to evaluate the efficacy of dimethyl fumarate (Tecfidera) and peginterferon beta-1a (Plegridy), both compared with placebo, in pediatric participants with RRMS.

Added 3 months ago

Search all clinical trials for Multiple sclerosis


Multiple sclerosis: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Multiple sclerosis